Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California. Show more
1800 Aston Avenue, Carlsbad, CA, 92008, United States
Market Cap
438.2M
52 Wk Range
$8.50 - $17.23
Previous Close
$16.05
Open
$16.07
Volume
114,686
Day Range
$15.76 - $16.43
Enterprise Value
370.9M
Cash
89.22M
Avg Qtr Burn
-7.358M
Insider Ownership
44.42%
Institutional Own.
40.31%
Qtr Updated
06/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
